Intravenous immunoglobulin in antiphospholipid syndrome and maternal floor infarction when standard treatment fails: A case report

American Journal of Perinatology

Volumn 23, Issue 2, 2006, Pages 125-129

  Chang, Phyllis ^a   Millar, Debra ^b,c   Tsang, Peter ^b,c   Lim, Kenneth ^b,c   Houlihan, Edwina ^c   Stephenson, Mary ^a,b,c  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c CHILDREN S AND WOMEN S HEALTH CENTRE OF BRITISH COLUMBIA   (Canada)

Author keywords

Antiphospholipid syndrome; IVIG; Maternal floor infarction

Indexed keywords

ACETYLSALICYLIC ACID; HEPARIN; IMMUNOGLOBULIN;

ADJUVANT THERAPY; ADULT; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; CASE REPORT; DRUG TREATMENT FAILURE; FEMALE; FETUS; FETUS MORTALITY; FETUS WASTAGE; HUMAN; MATERNAL FLOOR INFARCTION; MATERNAL MORBIDITY; MATERNAL MORTALITY; PELVIC ORGAN PROLAPSE; PREGNANCY; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; SPONTANEOUS ABORTION; STANDARD;

ADULT; ANTIPHOSPHOLIPID SYNDROME; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; GESTATIONAL AGE; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFARCTION; MATERNAL AGE; PARITY; PELVIC FLOOR; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL CARE; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 33644924868     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2006-931805     Document Type: Article

References (14)

1. Wilson W, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-1311
2. Backos M, Rai R, Baxter N, et al. Pregnancy complications in women with recurrent miscarriage associated with antiphospholipid antibodies treated with low dose aspirin and heparin. Br J Obstet Gynaecol 1999;106:102-107
3. Kutteh WH, Rote NS, Silver R. Antiphospholipid antibodies and reproduction: the antiphospholipid antibody syndrome. Am J Reprod Immunol 1999;41:133-152
4. Harris EN. The Second International Anticardiolipin Standardisation Workshop/The Kingston Antiphospholipid Antibody Study (KAPS) Group. Am J Clin Pathol 1990;94:476-484
5. di Somone N, Meroni PL, de Papa N, et al. Antiphospholipid antibodies affect trophoblast gonadotropin secretion and invasiveness by binding directly and through adhered beta2-glycoprotein I. Arthritis Rheum 2000;43:140-150
6. Branch DW, Peaceman AM, Druzin M, et al. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. Am J Obstet Gynecol 2000;182:122-127
7. Triolo G, Ferrante A, Ciccia F, et al. Randomized study of subcutaneous low molecular weight heparin plus aspirin versus intravenous immunoglobulin in the treatment of recurrent fetal loss associated with antiphospholipid antibodies. Arthritis Rheum 2003;48:728-731
8. Yu Z, Lennon VA. Mechanism of intravenous immune globulin therapy in antibody-mediated autoimmune disease. N Engl J Med 1999;340:227-228
9. Stephenson MD, Ensom M. An update on the role of immunotherapy in reproductive failure. Immunol Allergy Clin North Am 2002;22:623-642
10. Benirschke K, Driscoll SG. Maternal Floor Infarction: Pathology of the Human Placenta. New York: Springer-Verlag; 1967:328-330
11. Mandsager NT, Bendon R, Mostello D, et al. Maternal floor infarction of the placenta: prenatal diagnosis and clinical significance. Obstet Gynecol 1994;83:750-754
12. Donohoe S, Kingdom JCP, Mackie IJ. Affinity purified human antiphospholipid antibodies bind normal term placenta. Lupus 1999;8:525-531
13. Rand JH, Wu XX, Andree HA, et al. Pregnancy loss in the antiphospholipid antibody syndrome: a possible thrombogenic mechanism. N Engl J Med 1997;337:154-160
14. Sebire NJ, Backos M, Gaddal SE, et al. Placental pathology, antiphospholipid antibodies, and pregnancy outcome in recurrent miscarriage patients. Obstet Gynecol 2003;101:258-263